Mepolizumab and the treatment of chronic rhinosinusitis

Dr. Joseph Han discusses the results of the phase III SYNAPSE
trial, evaluating the efficacy and safety of mepolizumab in
patients with chronic rhinosinusitis.

Read the full article:
https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(21)00097-7/fulltext


Continue this conversation on social!
Follow us today at...
https://thelancet.bsky.social/
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv